MYCO.NE - Mydecine Innovations Group Inc.

Cboe CA - Cboe CA Real Time Price. Currency in CAD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
7.493
0
7.493
58.49
125.572
Cost of Revenue
0
0
0
37.37
94.048
Gross Profit
0
0
7.493
21.12
31.524
Operating Expenses
Research Development
4,247
3,589
3,960
1,291
-
Selling General and Administrative
15,692
9,983
14,745
10,071
3,338
Total Operating Expenses
20,168
16,389
22,692
11,654
3,488
Operating Income or Loss
-20,160
-16,389
-22,684
-11,633
-3,457
Interest Expense
742.445
911.594
205.267
182.866
68.31
Total Other Income/Expenses Net
-1,766
59.158
-693.508
-15,133
29.686
Income Before Tax
-22,669
-17,242
-23,583
-26,949
-3,508
Income from Continuing Operations
-22,669
-17,242
-23,583
-26,949
-3,508
Net Income
-22,353
-11,567
-28,897
-26,949
-3,508
Net Income available to common shareholders
-22,353
-11,567
-28,897
-26,949
-3,508
Basic EPS
-
-1.34
-6.17
-12.05
-48.00
Diluted EPS
-
-1.34
-6.17
-12.05
-48.00
Basic Average Shares
-
8,647
4,682
2,274
445.465
Diluted Average Shares
-
8,647
4,682
2,274
445.465
EBITDA
-
-16,201
-23,142
-26,676
-3,330